Lifeward (LFWD) Return on Capital Employed (2016 - 2026)
Lifeward (LFWD) reported Return on Capital Employed of 143.57% for Q1 2026, down 896.0% on a YoY basis from 18.04% in Q1 2025, and up 19.76% sequentially from 178.94% in Q4 2025.
Lifeward (LFWD) Return on Capital Employed (2016 - 2026) Analysis & Trends
Lifeward (LFWD) has 11 years of Return on Capital Employed data on file, last reported at 143.57% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 896.0% year-over-year to 143.57%; the trailing twelve-month figure through Mar 2026 stood at 143.57% (down 896.0% YoY), and the FY2025 full-year result was 134.25%, down 5410.0% from the prior year.
- Return on Capital Employed climbed to 143.57% in Q1 2026, from 178.94% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 15.69% in Q1 2022 to a low of 187.09% in Q3 2025.
- A 5-year average of 77.11% and a median of 52.31% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed surged 847 bps in 2022 and sank 13478 bps in 2025, its largest moves.
- Tracing LFWD's Return on Capital Employed over 5 years: stood at 26.27% in 2022, then sank by 65 bps to 43.4% in 2023, then sank by 142 bps to 105.17% in 2024, then slumped by 70 bps to 178.94% in 2025, then advanced by 20 bps to 143.57% in 2026.
- Business Quant data shows LFWD's Return on Capital Employed at 143.57% in Q1 2026, 178.94% in Q4 2025, and 187.09% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn | -143.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -143.57% |
| Dec 31, 2025 | -178.94% |
| Sep 30, 2025 | -187.09% |
| Jun 30, 2025 | -171.04% |
| Mar 31, 2025 | -134.61% |
| Dec 31, 2024 | -105.17% |
| Sep 30, 2024 | -52.31% |
| Jun 30, 2024 | -58.02% |
| Mar 31, 2024 | -52.41% |
| Dec 31, 2023 | -43.40% |
| Sep 30, 2023 | -41.10% |
| Jun 30, 2023 | -32.24% |
| Mar 31, 2023 | -28.33% |
| Dec 31, 2022 | -26.27% |
| Sep 30, 2022 | -22.68% |
| Jun 30, 2022 | -18.02% |
| Mar 31, 2022 | -15.69% |
| Dec 31, 2021 | -13.65% |
| Sep 30, 2021 | -14.36% |
| Jun 30, 2021 | -17.43% |